| Year |
Citation |
Score |
| 2021 |
Viglianti GA, Planelles V, Hanley TM. Interactions with Commensal and Pathogenic Bacteria Induce HIV-1 Latency in Macrophages through Altered Transcription Factor Recruitment to the LTR. Journal of Virology. PMID 33472928 DOI: 10.1128/JVI.02141-20 |
0.809 |
|
| 2016 |
Agosto LM, Hirnet JB, Michaels DH, Shaik-Dasthagirisaheb YB, Gibson FC, Viglianti G, Henderson AJ. Porphyromonas gingivalis-mediated signaling through TLR4 mediates persistent HIV infection of primary macrophages. Virology. 499: 72-81. PMID 27639573 DOI: 10.1016/J.Virol.2016.09.007 |
0.636 |
|
| 2016 |
Papadopoulos G, Shaik-Dasthagirisaheb YB, Huang N, Viglianti GA, Henderson AJ, Kantarci A, Gibson FI. Immunologic Environment Influences Macrophage Response to Porphyromonas gingivalis. Molecular Oral Microbiology. PMID 27346827 DOI: 10.1111/Omi.12168 |
0.33 |
|
| 2016 |
Moody KL, Uccellini MB, Avalos AM, Marshak-Rothstein A, Viglianti GA. Toll-Like Receptor-Dependent Immune Complex Activation of B Cells and Dendritic Cells. Methods in Molecular Biology (Clifton, N.J.). 1390: 249-72. PMID 26803634 DOI: 10.1007/978-1-4939-3335-8_16 |
0.376 |
|
| 2015 |
Kaczmarek Michaels K, Natarajan M, Euler Z, Alter G, Viglianti G, Henderson AJ. Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 194: 3267-74. PMID 25710909 DOI: 10.4049/Jimmunol.1402581 |
0.558 |
|
| 2011 |
Hanley TM, Viglianti GA. Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms. Journal of Virology. 85: 10834-50. PMID 21849441 DOI: 10.1128/Jvi.00789-11 |
0.804 |
|
| 2010 |
Avalos AM, Uccellini MB, Lenert P, Viglianti GA, Marshak-Rothstein A. FcγRIIB regulation of BCR/TLR-dependent autoreactive B-cell responses. European Journal of Immunology. 40: 2692-8. PMID 20809520 DOI: 10.1002/Eji.200940184 |
0.366 |
|
| 2010 |
Hanley TM, Blay Puryear W, Gummuluru S, Viglianti GA. PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection. Plos Pathogens. 6: e1000981. PMID 20617179 DOI: 10.1371/Journal.Ppat.1000981 |
0.79 |
|
| 2009 |
Yasuda K, Richez C, Uccellini MB, Richards RJ, Bonegio RG, Akira S, Monestier M, Corley RB, Viglianti GA, Marshak-Rothstein A, Rifkin IR. Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes. Journal of Immunology (Baltimore, Md. : 1950). 183: 3109-17. PMID 19648272 DOI: 10.4049/Jimmunol.0900399 |
0.31 |
|
| 2008 |
Uccellini MB, Busconi L, Green NM, Busto P, Christensen SR, Shlomchik MJ, Marshak-Rothstein A, Viglianti GA. Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha. Journal of Immunology (Baltimore, Md. : 1950). 181: 5875-84. PMID 18941176 DOI: 10.4049/Jimmunol.181.9.5875 |
0.339 |
|
| 2006 |
Busconi L, Lau CM, Tabor AS, Uccellini MB, Ruhe Z, Akira S, Viglianti GA, Rifkin IR, Marshak-Rothstein A. DNA and RNA autoantigens as autoadjuvants. Journal of Endotoxin Research. 12: 379-84. PMID 17254393 DOI: 10.1177/09680519060120060901 |
0.368 |
|
| 2005 |
Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, Christensen SR, Shlomchik MJ, Viglianti GA, Rifkin IR, Marshak-Rothstein A. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. The Journal of Experimental Medicine. 202: 1171-7. PMID 16260486 DOI: 10.1084/Jem.20050630 |
0.358 |
|
| 2005 |
Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunological Reviews. 204: 27-42. PMID 15790348 DOI: 10.1111/J.0105-2896.2005.00239.X |
0.324 |
|
| 2004 |
Marshak-Rothstein A, Busconi L, Lau CM, Tabor AS, Leadbetter EA, Akira S, Krieg AM, Lipford GB, Viglianti GA, Rifkin IR. Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells. Journal of Endotoxin Research. 10: 247-51. PMID 15373969 DOI: 10.1177/09680519040100040801 |
0.396 |
|
| 2004 |
Kiefer HL, Hanley TM, Marcello JE, Karthik AG, Viglianti GA. Retinoic acid inhibition of chromatin remodeling at the human immunodeficiency virus type 1 promoter. Uncoupling of histone acetylation and chromatin remodeling. The Journal of Biological Chemistry. 279: 43604-13. PMID 15299018 DOI: 10.1074/Jbc.M408069200 |
0.712 |
|
| 2004 |
Marshak-Rothstein A, Busconi L, Rifkin IR, Viglianti GA. The stimulation of Toll-like receptors by nuclear antigens: a link between apoptosis and autoimmunity. Rheumatic Diseases Clinics of North America. 30: 559-74, ix. PMID 15261341 DOI: 10.1016/J.Rdc.2004.04.005 |
0.326 |
|
| 2004 |
Hanley TM, Kiefer HL, Schnitzler AC, Marcello JE, Viglianti GA. Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophages. Journal of Virology. 78: 2819-30. PMID 14990701 DOI: 10.1128/Jvi.78.6.2819-2830.2004 |
0.731 |
|
| 2003 |
Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity. 19: 837-47. PMID 14670301 DOI: 10.1016/S1074-7613(03)00323-6 |
0.723 |
|
| 2002 |
Gallina A, Hanley TM, Mandel R, Trahey M, Broder CC, Viglianti GA, Ryser HJ. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. The Journal of Biological Chemistry. 277: 50579-88. PMID 12218051 DOI: 10.1074/Jbc.M204547200 |
0.781 |
|
| 2002 |
Brown XQ, Hanley TM, Viglianti GA. Interleukin 1 beta and interleukin 6 potentiate retinoic acid-mediated repression of human immunodeficiency virus type 1 replication in macrophages. Aids Research and Human Retroviruses. 18: 649-56. PMID 12079560 DOI: 10.1089/088922202760019347 |
0.712 |
|
| 1998 |
Maciaszek JW, Coniglio SJ, Talmage DA, Viglianti GA. Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication. Journal of Virology. 72: 5862-9. PMID 9621047 DOI: 10.1128/Jvi.72.7.5862-5869.1998 |
0.609 |
|
| 1997 |
Viglianti GA, Parada NA, Maciaszek JW, Kornfeld H, Center DM, Cruikshank WW. IL-16 anti-HIV-1 therapy [3] Nature Medicine. 3: 938. PMID 9288705 DOI: 10.1038/Nm0997-938 |
0.476 |
|
| 1997 |
Cruikshank WW, Doctrow SR, Falvo MS, Huffman K, Maciaszek J, Viglianti G, Raina J, Kornfeld H, Malfroy B. A lipidated Anti-Tat antibody enters living cells and blocks HIV-1 viral replication Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 14: 193-203. PMID 9117450 DOI: 10.1097/00042560-199703010-00001 |
0.457 |
|
| 1997 |
Reinhart TA, Rogan MJ, Viglianti GA, Rausch DM, Eiden LE, Haase AT. A new approach to investigating the relationship between productive infection and cytopathicity in vivo Nature Medicine. 3: 218-221. PMID 9018242 DOI: 10.1038/Nm0297-218 |
0.446 |
|
| 1997 |
Maciaszek JW, Parada NA, Cruikshank WW, Center DM, Kornfeld H, Viglianti GA. IL-16 Represses HIV-1 Promoter Activity Journal of Immunology. 158: 5-8. PMID 8977168 |
0.421 |
|
| 1994 |
Maciaszek JW, Talmage DA, Viglianti GA. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism. Journal of Virology. 68: 6598-604. PMID 8083995 DOI: 10.1128/Jvi.68.10.6598-6604.1994 |
0.622 |
|
| 1988 |
Viglianti GA, Mullins JI. Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1 Journal of Virology. 62: 4523-4532. PMID 2846868 DOI: 10.1128/Jvi.62.12.4523-4532.1988 |
0.487 |
|
| 1987 |
Kornfeld H, Riedel N, Viglianti GA, Hirsch V, Mullins JI. Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses Nature. 326: 610-613. PMID 3104797 DOI: 10.1038/326610A0 |
0.517 |
|
| Show low-probability matches. |